## Abstract Mesenchymal stem cells (MSC) offer great promise in therapies aimed at repairing, replacing or regenerating damaged or diseased tissues and organs. This potential is due to their capacity for self‐renewal, ability to differentiate down a range of lineages, and potential in autologous th
Hypoxia and stem cell-based engineering of mesenchymal tissues
✍ Scribed by Teng Ma; Warren L. Grayson; Mirjam Fröhlich; Gordana Vunjak-Novakovic
- Publisher
- American Institute of Chemical Engineers
- Year
- 2009
- Tongue
- English
- Weight
- 801 KB
- Volume
- 25
- Category
- Article
- ISSN
- 8756-7938
- DOI
- 10.1002/btpr.128
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract There is a growing need for efficient mesenchymal stem cell (MSC) production processes for a wide spectrum of clinical conditions ranging from the treatment of life‐threatening graft‐__versus__‐host disease to cartilage repair. Development of cell and tissue engineered products derived
## Abstract This in vivo pilot study explored the use of mesenchymal stem cell (MSC) containing tissue engineering constructs in repair of osteochondral defects. Osteochondral defects were created in the medial condyles of both knees of 16 miniature pigs. One joint received a cell/collagen tissue e
## Abstract Adult mesenchymal stem cells (MSCs) can be isolated from bone marrow or marrow aspirates and because they are culture‐dish adherent, they can be expanded in culture while maintaining their multipotency. The MSCs have been used in preclinical models for tissue engineering of bone, cartil
## Abstract Defects of the meniscus greatly alter knee function and predispose the joint to degenerative changes. The purpose of this study was to test a recently developed cell‐scaffold combination for the repair of a critical‐size defect of the rabbit medial meniscus. A bilateral, complete resect